aluates Reports

$ 0.0

Automative

Global Gene Therapies for Cancer Treatment Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-0Q13672

Global Gene Therapies for Cancer Treatment Market Research Report 2023

BUY CHAPTERS

Global Gene Therapies for Cancer Treatment Market Research Report 2025

Code: QYRE-Auto-0Q13672

Report

September 2025

Pages:83

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Takara Bio

Tocagen

VBL Therapeutics

Cold Genesys

Genprex

Momotaro-Gene

MultiVir

SynerGene Therapeutics

ZIOPHARM Oncology

Anchiano Therapeutics

Celgene

CELSION

Bluebird bio

Gene Therapies for Cancer Treatment Market

The global market for Gene Therapies for Cancer Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

In the medicine field, gene therapy is the therapeutic delivery of nucleic acid into a patient"s cells as a drug to treat disease.

North American market for Gene Therapies for Cancer Treatment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Gene Therapies for Cancer Treatment is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Gene Therapies for Cancer Treatment in Cancer Research Centers is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Gene Therapies for Cancer Treatment include Takara Bio, Tocagen, VBL Therapeutics, Cold Genesys, Genprex, Momotaro-Gene, MultiVir, SynerGene Therapeutics, Ziopharm Oncology, Anchiano Therapeutics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Gene Therapies for Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapies for Cancer Treatment.

The Gene Therapies for Cancer Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene Therapies for Cancer Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gene Therapies for Cancer Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Gene Therapies for Cancer Treatment Market Report

Report Metric	Details
Report Name	Gene Therapies for Cancer Treatment Market
Segment by Type	Somatic Cell Gene Therapy (SCGT) Germline Gene Therapy (GGT)
Segment by Application	Cancer Research Centers Diagnostic Laboratories Cancer Hospitals Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Takara Bio, Tocagen, VBL Therapeutics, Cold Genesys, Genprex, Momotaro-Gene, MultiVir, SynerGene Therapeutics, Ziopharm Oncology, Anchiano Therapeutics, Celgene, Celsion, Bluebird Bio
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Therapies for Cancer Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gene Therapies for Cancer Treatment Market report?

Ans: The main players in the Gene Therapies for Cancer Treatment Market are Takara Bio, Tocagen, VBL Therapeutics, Cold Genesys, Genprex, Momotaro-Gene, MultiVir, SynerGene Therapeutics, Ziopharm Oncology, Anchiano Therapeutics, Celgene, Celsion, Bluebird Bio

What are the Application segmentation covered in the Gene Therapies for Cancer Treatment Market report?

Ans: The Applications covered in the Gene Therapies for Cancer Treatment Market report are Cancer Research Centers, Diagnostic Laboratories, Cancer Hospitals, Others

What are the Type segmentation covered in the Gene Therapies for Cancer Treatment Market report?

Ans: The Types covered in the Gene Therapies for Cancer Treatment Market report are Somatic Cell Gene Therapy (SCGT), Germline Gene Therapy (GGT)

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gene Therapies for Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Somatic Cell Gene Therapy (SCGT)

1.2.3 Germline Gene Therapy (GGT)

1.3 Market by Application

1.3.1 Global Gene Therapies for Cancer Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Cancer Research Centers

1.3.3 Diagnostic Laboratories

1.3.4 Cancer Hospitals

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gene Therapies for Cancer Treatment Market Perspective (2020-2031)

2.2 Global Gene Therapies for Cancer Treatment Growth Trends by Region

2.2.1 Global Gene Therapies for Cancer Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Gene Therapies for Cancer Treatment Historic Market Size by Region (2020-2025)

2.2.3 Gene Therapies for Cancer Treatment Forecasted Market Size by Region (2026-2031)

2.3 Gene Therapies for Cancer Treatment Market Dynamics

2.3.1 Gene Therapies for Cancer Treatment Industry Trends

2.3.2 Gene Therapies for Cancer Treatment Market Drivers

2.3.3 Gene Therapies for Cancer Treatment Market Challenges

2.3.4 Gene Therapies for Cancer Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Gene Therapies for Cancer Treatment Players by Revenue

3.1.1 Global Top Gene Therapies for Cancer Treatment Players by Revenue (2020-2025)

3.1.2 Global Gene Therapies for Cancer Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Gene Therapies for Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Gene Therapies for Cancer Treatment Revenue

3.4 Global Gene Therapies for Cancer Treatment Market Concentration Ratio

3.4.1 Global Gene Therapies for Cancer Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gene Therapies for Cancer Treatment Revenue in 2024

3.5 Global Key Players of Gene Therapies for Cancer Treatment Head office and Area Served

3.6 Global Key Players of Gene Therapies for Cancer Treatment, Product and Application

3.7 Global Key Players of Gene Therapies for Cancer Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Therapies for Cancer Treatment Breakdown Data by Type

4.1 Global Gene Therapies for Cancer Treatment Historic Market Size by Type (2020-2025)

4.2 Global Gene Therapies for Cancer Treatment Forecasted Market Size by Type (2026-2031)

5 Gene Therapies for Cancer Treatment Breakdown Data by Application

5.1 Global Gene Therapies for Cancer Treatment Historic Market Size by Application (2020-2025)

5.2 Global Gene Therapies for Cancer Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Gene Therapies for Cancer Treatment Market Size (2020-2031)

6.2 North America Gene Therapies for Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Gene Therapies for Cancer Treatment Market Size by Country (2020-2025)

6.4 North America Gene Therapies for Cancer Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Gene Therapies for Cancer Treatment Market Size (2020-2031)

7.2 Europe Gene Therapies for Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Gene Therapies for Cancer Treatment Market Size by Country (2020-2025)

7.4 Europe Gene Therapies for Cancer Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Gene Therapies for Cancer Treatment Market Size (2020-2031)

8.2 Asia-Pacific Gene Therapies for Cancer Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Gene Therapies for Cancer Treatment Market Size (2020-2031)

9.2 Latin America Gene Therapies for Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Gene Therapies for Cancer Treatment Market Size by Country (2020-2025)

9.4 Latin America Gene Therapies for Cancer Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Gene Therapies for Cancer Treatment Market Size (2020-2031)

10.2 Middle East & Africa Gene Therapies for Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Takara Bio

11.1.1 Takara Bio Company Details

11.1.2 Takara Bio Business Overview

11.1.3 Takara Bio Gene Therapies for Cancer Treatment Introduction

11.1.4 Takara Bio Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)

11.1.5 Takara Bio Recent Development

11.2 Tocagen

11.2.1 Tocagen Company Details

11.2.2 Tocagen Business Overview

11.2.3 Tocagen Gene Therapies for Cancer Treatment Introduction

11.2.4 Tocagen Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)

11.2.5 Tocagen Recent Development

11.3 VBL Therapeutics

11.3.1 VBL Therapeutics Company Details

11.3.2 VBL Therapeutics Business Overview

11.3.3 VBL Therapeutics Gene Therapies for Cancer Treatment Introduction

11.3.4 VBL Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)

11.3.5 VBL Therapeutics Recent Development

11.4 Cold Genesys

11.4.1 Cold Genesys Company Details

11.4.2 Cold Genesys Business Overview

11.4.3 Cold Genesys Gene Therapies for Cancer Treatment Introduction

11.4.4 Cold Genesys Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)

11.4.5 Cold Genesys Recent Development

11.5 Genprex

11.5.1 Genprex Company Details

11.5.2 Genprex Business Overview

11.5.3 Genprex Gene Therapies for Cancer Treatment Introduction

11.5.4 Genprex Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)

11.5.5 Genprex Recent Development

11.6 Momotaro-Gene

11.6.1 Momotaro-Gene Company Details

11.6.2 Momotaro-Gene Business Overview

11.6.3 Momotaro-Gene Gene Therapies for Cancer Treatment Introduction

11.6.4 Momotaro-Gene Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)

11.6.5 Momotaro-Gene Recent Development

11.7 MultiVir

11.7.1 MultiVir Company Details

11.7.2 MultiVir Business Overview

11.7.3 MultiVir Gene Therapies for Cancer Treatment Introduction

11.7.4 MultiVir Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)

11.7.5 MultiVir Recent Development

11.8 SynerGene Therapeutics

11.8.1 SynerGene Therapeutics Company Details

11.8.2 SynerGene Therapeutics Business Overview

11.8.3 SynerGene Therapeutics Gene Therapies for Cancer Treatment Introduction

11.8.4 SynerGene Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)

11.8.5 SynerGene Therapeutics Recent Development

11.9 Ziopharm Oncology

11.9.1 Ziopharm Oncology Company Details

11.9.2 Ziopharm Oncology Business Overview

11.9.3 Ziopharm Oncology Gene Therapies for Cancer Treatment Introduction

11.9.4 Ziopharm Oncology Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)

11.9.5 Ziopharm Oncology Recent Development

11.10 Anchiano Therapeutics

11.10.1 Anchiano Therapeutics Company Details

11.10.2 Anchiano Therapeutics Business Overview

11.10.3 Anchiano Therapeutics Gene Therapies for Cancer Treatment Introduction

11.10.4 Anchiano Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)

11.10.5 Anchiano Therapeutics Recent Development

11.11 Celgene

11.11.1 Celgene Company Details

11.11.2 Celgene Business Overview

11.11.3 Celgene Gene Therapies for Cancer Treatment Introduction

11.11.4 Celgene Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)

11.11.5 Celgene Recent Development

11.12 Celsion

11.12.1 Celsion Company Details

11.12.2 Celsion Business Overview

11.12.3 Celsion Gene Therapies for Cancer Treatment Introduction

11.12.4 Celsion Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)

11.12.5 Celsion Recent Development

11.13 Bluebird Bio

11.13.1 Bluebird Bio Company Details

11.13.2 Bluebird Bio Business Overview

11.13.3 Bluebird Bio Gene Therapies for Cancer Treatment Introduction

11.13.4 Bluebird Bio Revenue in Gene Therapies for Cancer Treatment Business (2020-2025)

11.13.5 Bluebird Bio Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Takara Bio

Tocagen

VBL Therapeutics

Cold Genesys

Genprex

Momotaro-Gene

MultiVir

SynerGene Therapeutics

ZIOPHARM Oncology

Anchiano Therapeutics

Celgene

CELSION

Bluebird bio

List of Tables

Table 1. Global Gene Therapies for Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Somatic Cell Gene Therapy (SCGT)

Table 3. Key Players of Germline Gene Therapy (GGT)

Table 4. Global Gene Therapies for Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Gene Therapies for Cancer Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Gene Therapies for Cancer Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Gene Therapies for Cancer Treatment Market Share by Region (2020-2025)

Table 8. Global Gene Therapies for Cancer Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Gene Therapies for Cancer Treatment Market Share by Region (2026-2031)

Table 10. Gene Therapies for Cancer Treatment Market Trends

Table 11. Gene Therapies for Cancer Treatment Market Drivers

Table 12. Gene Therapies for Cancer Treatment Market Challenges

Table 13. Gene Therapies for Cancer Treatment Market Restraints

Table 14. Global Gene Therapies for Cancer Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Gene Therapies for Cancer Treatment Market Share by Players (2020-2025)

Table 16. Global Top Gene Therapies for Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapies for Cancer Treatment as of 2024)

Table 17. Ranking of Global Top Gene Therapies for Cancer Treatment Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Gene Therapies for Cancer Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Gene Therapies for Cancer Treatment, Headquarters and Area Served

Table 20. Global Key Players of Gene Therapies for Cancer Treatment, Product and Application

Table 21. Global Key Players of Gene Therapies for Cancer Treatment, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Gene Therapies for Cancer Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Gene Therapies for Cancer Treatment Revenue Market Share by Type (2020-2025)

Table 25. Global Gene Therapies for Cancer Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Gene Therapies for Cancer Treatment Revenue Market Share by Type (2026-2031)

Table 27. Global Gene Therapies for Cancer Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Gene Therapies for Cancer Treatment Revenue Market Share by Application (2020-2025)

Table 29. Global Gene Therapies for Cancer Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Gene Therapies for Cancer Treatment Revenue Market Share by Application (2026-2031)

Table 31. North America Gene Therapies for Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Gene Therapies for Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Gene Therapies for Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Gene Therapies for Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Gene Therapies for Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Gene Therapies for Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Gene Therapies for Cancer Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Gene Therapies for Cancer Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Gene Therapies for Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Gene Therapies for Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Gene Therapies for Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Gene Therapies for Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Gene Therapies for Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 46. Takara Bio Company Details

Table 47. Takara Bio Business Overview

Table 48. Takara Bio Gene Therapies for Cancer Treatment Product

Table 49. Takara Bio Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)

Table 50. Takara Bio Recent Development

Table 51. Tocagen Company Details

Table 52. Tocagen Business Overview

Table 53. Tocagen Gene Therapies for Cancer Treatment Product

Table 54. Tocagen Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)

Table 55. Tocagen Recent Development

Table 56. VBL Therapeutics Company Details

Table 57. VBL Therapeutics Business Overview

Table 58. VBL Therapeutics Gene Therapies for Cancer Treatment Product

Table 59. VBL Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)

Table 60. VBL Therapeutics Recent Development

Table 61. Cold Genesys Company Details

Table 62. Cold Genesys Business Overview

Table 63. Cold Genesys Gene Therapies for Cancer Treatment Product

Table 64. Cold Genesys Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)

Table 65. Cold Genesys Recent Development

Table 66. Genprex Company Details

Table 67. Genprex Business Overview

Table 68. Genprex Gene Therapies for Cancer Treatment Product

Table 69. Genprex Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)

Table 70. Genprex Recent Development

Table 71. Momotaro-Gene Company Details

Table 72. Momotaro-Gene Business Overview

Table 73. Momotaro-Gene Gene Therapies for Cancer Treatment Product

Table 74. Momotaro-Gene Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)

Table 75. Momotaro-Gene Recent Development

Table 76. MultiVir Company Details

Table 77. MultiVir Business Overview

Table 78. MultiVir Gene Therapies for Cancer Treatment Product

Table 79. MultiVir Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)

Table 80. MultiVir Recent Development

Table 81. SynerGene Therapeutics Company Details

Table 82. SynerGene Therapeutics Business Overview

Table 83. SynerGene Therapeutics Gene Therapies for Cancer Treatment Product

Table 84. SynerGene Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)

Table 85. SynerGene Therapeutics Recent Development

Table 86. Ziopharm Oncology Company Details

Table 87. Ziopharm Oncology Business Overview

Table 88. Ziopharm Oncology Gene Therapies for Cancer Treatment Product

Table 89. Ziopharm Oncology Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)

Table 90. Ziopharm Oncology Recent Development

Table 91. Anchiano Therapeutics Company Details

Table 92. Anchiano Therapeutics Business Overview

Table 93. Anchiano Therapeutics Gene Therapies for Cancer Treatment Product

Table 94. Anchiano Therapeutics Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)

Table 95. Anchiano Therapeutics Recent Development

Table 96. Celgene Company Details

Table 97. Celgene Business Overview

Table 98. Celgene Gene Therapies for Cancer Treatment Product

Table 99. Celgene Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)

Table 100. Celgene Recent Development

Table 101. Celsion Company Details

Table 102. Celsion Business Overview

Table 103. Celsion Gene Therapies for Cancer Treatment Product

Table 104. Celsion Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)

Table 105. Celsion Recent Development

Table 106. Bluebird Bio Company Details

Table 107. Bluebird Bio Business Overview

Table 108. Bluebird Bio Gene Therapies for Cancer Treatment Product

Table 109. Bluebird Bio Revenue in Gene Therapies for Cancer Treatment Business (2020-2025) & (US$ Million)

Table 110. Bluebird Bio Recent Development

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

Table 114. Authors List of This Report

List of Figures

Figure 1. Gene Therapies for Cancer Treatment Picture

Figure 2. Global Gene Therapies for Cancer Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Gene Therapies for Cancer Treatment Market Share by Type: 2024 VS 2031

Figure 4. Somatic Cell Gene Therapy (SCGT) Features

Figure 5. Germline Gene Therapy (GGT) Features

Figure 6. Global Gene Therapies for Cancer Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Gene Therapies for Cancer Treatment Market Share by Application: 2024 VS 2031

Figure 8. Cancer Research Centers Case Studies

Figure 9. Diagnostic Laboratories Case Studies

Figure 10. Cancer Hospitals Case Studies

Figure 11. Others Case Studies

Figure 12. Gene Therapies for Cancer Treatment Report Years Considered

Figure 13. Global Gene Therapies for Cancer Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Gene Therapies for Cancer Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Gene Therapies for Cancer Treatment Market Share by Region: 2024 VS 2031

Figure 16. Global Gene Therapies for Cancer Treatment Market Share by Players in 2024

Figure 17. Global Top Gene Therapies for Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapies for Cancer Treatment as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Gene Therapies for Cancer Treatment Revenue in 2024

Figure 19. North America Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Gene Therapies for Cancer Treatment Market Share by Country (2020-2031)

Figure 21. United States Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Gene Therapies for Cancer Treatment Market Share by Country (2020-2031)

Figure 25. Germany Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Gene Therapies for Cancer Treatment Market Share by Region (2020-2031)

Figure 33. China Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Gene Therapies for Cancer Treatment Market Share by Country (2020-2031)

Figure 41. Mexico Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Gene Therapies for Cancer Treatment Market Share by Country (2020-2031)

Figure 45. Turkey Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Gene Therapies for Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Takara Bio Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)

Figure 49. Tocagen Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)

Figure 50. VBL Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)

Figure 51. Cold Genesys Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)

Figure 52. Genprex Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)

Figure 53. Momotaro-Gene Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)

Figure 54. MultiVir Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)

Figure 55. SynerGene Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)

Figure 56. Ziopharm Oncology Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)

Figure 57. Anchiano Therapeutics Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)

Figure 58. Celgene Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)

Figure 59. Celsion Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)

Figure 60. Bluebird Bio Revenue Growth Rate in Gene Therapies for Cancer Treatment Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Gene Therapy For Cancer Market Research Report 2024

Global Human Gene Therapy Market Research Report 2025

Gene Therapy on Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene based Therapy Medicinal Market Research Report 2024

Global Gene Delivery or Gene Therapy Drug Market Research Report 2025

Global Gene based Advanced Therapy Medicinal Market Research Report 2025

Viral Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gene Delivery System Technology Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Therapy Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Gene Therapy based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Therapy in Oncology Market Research Report 2024

Drug Based on Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gene based Advanced Therapy Medical Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drugs Based on Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Delivery System Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

Global Cell and Gene Therapy Market Research Report 2024

Global Gene Therapy for Inherited Genetic Disorders Market Insights Forecast to 2030

Gene Therapy on Neurological Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Nucleic Acid Based Gene Therapy Market Research Report 2025

RELATED REPORTS

Global Fixation Device for Radiotherapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4H16852

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Group A Streptococcus for Injection Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-37K16619

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Boron Neutron Capture Therapy System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30U16301

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Radioactive Glass Microsphere Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-2G16953

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions